Scaffold Technology Market (By Product: Hydrogels, Micropatterned Surface Microplates, and Nanofiber Based Scaffolds; By Application: Neurology, Orthopedics, Dental, Cardiology & Vascular, Cancer, Skin & Integumentary, GI & Gynecologyand Urology; By End-User: Stem Cell Therapy, Tissue Engineering & Regenerative Medicine, Drug Discover, and Others) - Global Industry Analysis, Market Size, Share, Growth, Trends, Regional Outlook, And Segment Forecasts, 2022 - 2030

The global scaffold technology market size was estimated at US$ 1.14 billion in 2021 and is expected to hit around US$ 2.63 billion by 2030 with a registered CAGR of 9.68% during the forecast period 2022 to 2030.

Increasing application in the replacement, regeneration, and refurbishment of damaged and unhealthy tissues and organs are driving the growth of global scaffold technology. Moreover, the cumulative R&D venture, rising need for organ transplantation, progression in tissue engineering are driving the growth of market.

Scaffold Technology Market Size 2022 to 2030

Key Takeaway

  • By type, the hydrogels segment accounted revenue share of around 43.2% in 2021. However, the nanofiber-based scaffolds segment is growing at a CAGR of 9.8% from 2022 to 2030.
  • By application, the stem cell therapy, tissue engineering, and regenerative medicine segment has held revenue share of around 66.5% in 2021.
  • By disease type, the orthopedics, spine, and musculoskeletal segment has captured 51% revenue shar in 2021.
  • By end-use, the biotechnology and pharmaceutical sector segment has accounted revenue share of over 46.9% in 2021.
  • The hospitals and diagnostic centers segment are poised to grow at a CAGR of 8.8% from 2022 to 2030.
  • By, regional, the North America has accounted revenue share of over 41% in 2021.
  • The AsiaPacific scaffold technology market is growing faster over the forecast period.

Key market Insights:

The tissue engineering is multidisciplinary and interdisciplinary sector. It has revealed huge promise in producing living substitutes for harvested organs and tissues for reconstructive and transplantation surgery. Materials and fabrication technologies are significantly imperative for tissue engineering while designing artificial, temporary extracellular matrices or scaffolds which support 3D tissue formation. The vital influence motivating the scaffold technology is the snowballing R&D efforts and the benefit of substituting animal trials with the help of real time biological environment research. This research considers regulatory and ethical issues. With the snowballing application of scaffolds, researchers can better comprehend biological activity of specific treatment on human body. As synthetic scaffold does mimic the biological environment, they are obviously favored over animal trials. Further, technology has progressed the way scaffold are manufactured. Producers are now including the use of 3D printing technology in the scaffold manufacturing procedure.

Significant Market Trends:

Hydrogels Segment Stated Major Market Stake in 2020

Hydrogels segment verified the prime market share more than 40% in the scaffold technology market in 2020. This high share is on account of properties connected to the use of hydrogels, like ease of loading cells and drugs for controlled drug delivery. Since, past few years, hydrogels have attained request as a foremost candidate in tissue engineering and 3D cell cultivation. Continuing technological progressions in the microfabrication of hydrogels are predictable to push growth of this segment.The nanofiber-based scaffolds segment is predicted to eyewitness the rapid growth throughout the prediction period. The nanoscale fibrous structures with interconnecting pores intended by the electrospinning technique ease the development of artificial functional tissues through tissue engineering.

Report Scope of th Scaffold Technology Market

Report Highlights Details
Market Size US$ 2.63 Billion by 2030
Growth Rate CAGR of 9.68% From 2022 to 2030
Base Year 2021
Historic Data 2017 to 2021
Forecast Period 2022 to 2030
Segments Covered Type, Application, End-User
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Merck KGaA, Avacta Life Sciences Limited, Nanofiber Solutions, 4titude, Tecan Trading AG, REPROCELL Inc., Matricel GmbH, 3D Biomatrix, Vericel Corporation


Stem Cell Therapy, Tissue Engineering & Regenerative Medicine Dominated the Marketplace throughout the Prediction Timeframe

Among different end-user segments, regenerative medicine, stem cell therapy, and tissue engineering led the global market revenue with a share more than 66.5% in 2021 and is probable to observe the robust growth during 2021 to 2030. High application of scaffolds in aesthetic surgeries, wound healing, soft tissue tumor repair, periodontology, abdominal wall repair, and colorectal surgeries augment the revenue generation in this segment. The requirement for portable and robust tools for drug development and discovery rushes the application of scaffold technology in the drug discovery sector. The ability of 3D cellular models to imitate the microenvironment for the etiology studies and pathway elucidation has shown reimbursements over traditional processes procedures including mono layer cell cultivation

Orthopedics, musculoskeletal, and spine is Anticipated to Rule the Scaffold technology Market Revenue

Orthopedics, musculoskeletal, and spine segment seized the major revenue cut above 51% in 2021 due to upsurge in the occurrence of orthopedic and musculoskeletal complications. Hence, the arrival of novel technologies like electro spun nanofiber scaffolds produced for the engineering of orthopedic tissues flourishes the segment growth. Additionally, neurology segment is likely to inflate at the rapid growth rate throughout the prediction period on account of incessant R&D in regenerative solutions in case of neurological ailments.

North America is Projected to be the Largest Market for Scaffold technology

The research report incorporates key trends and prospects of scaffold technology products across different geographical regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.North America is anticipated to control the scaffold technology market on account of well-developed infrastructure, continuing research, and the attendance of key market participants in the region. North America rules the market due to huge number of cancer patients recorded and cumulative death toll on account of cancer. As per WHO, cancer comes 2nd as the chief reason of death worldwide with around 9.6 million deaths in 2018 which influences the market growth. Upsurge in funding by government and regional companies subsidizes the market growth with continuous R&D attempts that aid in the growth of this technology.

Though, the scaffold technology market in Asia Pacific is likely to register the highest growth rate throughout the estimate period, due to the snowballing government focus on increasing research and development in the pharmaceutical sector and the refining health care infrastructure in the region.

Global Scaffold Technology Market 2021 to 2030

Uppermost Players Contending in the Market:

Moreover, the usage of scaffold is growing in stem cell research as well with incremental number of clinical trials commenced with stem cells scaffolds. Scientists from the Universities of Bristol and Liverpool are accomplishing clinical trial on humans along with their live bandage. The bandage made from stem cells cantransform the forecast and treatment of sporting knee wound. Meniscal tears hurt by main population in the Europe and U.S. are problematic to repair as there is absence of blood supply in the white zone of meniscus. The bandage was advanced by Azellon got subsidy from Innovate UK. The stem cell research was a close partnership amid business, hospitals and universities.

Prominent market contestants are accenting on strategies like new product introduction, business expansion, associations and acquisition to survive the sturdy market rivalry.

Foremost competitors challenging in global scaffold technology market are as follows:

  • Merck KGaA
  • Avacta Life Sciences Limited
  • Nanofiber Solutions
  • 4titude
  • Tecan Trading AG
  • Matricel GmbH
  • 3D Biomatrix
  • Vericel Corporation

Major Market Segments Covered:

By Type

  • Hydrogels
  • Micropatterned Surface Microplates
  • Nanofiber Based Scaffolds

By End-User

  • Stem Cell Therapy, Tissue Engineering & Regenerative Medicine
  • Drug Discover
  • Others

By Application

  • Neurology
  • Urology
  • Orthopedics
  • Dental
  • Cardiology & Vascular
  • Cancer
  • Skin & Integumentary
  • GI & Gynecology
  • Others

By Material

  • Bio-inert
  • Bioresorbable
  • Bioactive

By Geography

  • North America
      • U.S.
      • Canada
  • Europe
      • Germany
      • France
      • United Kingdom
      • Rest of Europe
  • Asia Pacific
      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
  • Latin America
      • Brazil
      • Rest of Latin America
  • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa

Frequently Asked Questions

What is the current size of the global scaffold technology market?
According to Precedence Research, the global scaffold technology market size estimated at US$ 1.14 billion in 2021 and is expected to be worth around US$ 2.63 billion by 2030.
What is the CAGR of scaffold technology market?
The global scaffold technology market is expected to grow at a CAGR of 9.68% from 2022 to 2030.
Which segment was accounted for the largest scaffold technology market share in 2021?
In 2021, hydrogels segment verified the prime market share more than 43.2% in the scaffold technology market.
Which region was accounted for the largest scaffold technology market revenue in 2021?
North America led the global market revenue with share above 41% in 2021. This can be credited to an upsurge in stem cell researcher generative medicine research, increase in funds to enlarge the applications of these technologies and an established healthcare framework.
Why Asia Pacific region is predictable to record the rapid CAGR during the prediction period?
Asia Pacific is predictable to record the rapid CAGR during the prediction period due to the occurrence of government agencies that emphasis on stem cell and regenerative medicine research.
Who are the key players in scaffold technology market?
Foremost companies in the scaffold technology industry comprises of 3D Biotek LLC, ReproCELL Europe Ltd. (Reinnervate), Becton, Dickinson and Company, Medtronic (Covidien plc), 3D Biomatrix, Avacta Life Sciences Limited, Merck KGaA (Sigma-Aldrich Co. LLC), Nanofiber Solutions, Acelity (LifeCell Corporation), Molecular Matrix, Inc., NuVasive, Inc., Molecular PartnersPelo Biotech GmbH, Vericel Corporation,Thermo Fisher Scientific, Inc., and Xanofi.
What are the factors driving the scaffold technology market?
Increasing application in the replacement, regeneration, and refurbishment of damaged and unhealthy tissues and organs are driving the growth of global scaffold technology. The cumulative R&D venture, rising need for organ transplantation, progression in tissue engineering are also driving the market growth.
  • Report Code:1208
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:November 2022


   USD 5900
   USD 7900
   USD 9900


No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample